Admn order hits at nexus between doc-surgical implant supplier at PGI
Cracking down on the alleged nexus between doctors and surgical implants suppliers at the advanced cardiac centre (ACC) of Postgraduate Institute of Medical Education and Research (PGIMER), the administration has instructed all vendors to come via central government’s AMRIT outlet, an affordable price shop.punjab Updated: Nov 18, 2016 19:57 IST
Cracking down on the alleged nexus between doctors and surgical implants suppliers at the advanced cardiac centre (ACC) of Postgraduate Institute of Medical Education and Research (PGIMER), the administration has instructed all vendors to come via central government’s AMRIT outlet, an affordable price shop.
The move has caused discontent among some doctors.
“As per instructions of the administration, the coronary angioplasty items and medicines will be purchased only through AMRIT. All vendors are advised to come through AMRIT for proper billing and for convenience of patients,” read the notice issued by Yash Paul Sharma, head, advanced cardiac centre.
The security staff has been advised not to issue any letters allowing other drug companies. The notice was issued almost a week after a circular was issued by Dr Vipin Koushal, officer in-charge, private grant Cell, PGI.
“The items which are not available with the AMRIT pharmacy will be procured from RC (rate contract) or alternative source,” reads the circular. “The letter of is about purchase through AMRIT pharmacy for private grant patients and not for others. Kindly correspondence with the administration for clear guidelines before passing a vague office order,” Dr Rajesh Vijayvergiya of ACC remarked.
Docs say AMRIT outlet stents inferior; HoD discards claim
The HoD notice has created unrest among some doctors, who do not seem happy with the order. A source said two doctors ended up in a heated argument outside the cath lab after they were denied to take implants from direct vendors/company representatives.
Dr Rajesh Vijayvergiya, professor, ACC said, “AMRIT outlet is not providing USFDA-approved stents, which are of better quality. The AMRIT outlet is providing inferior quality products, which can lead to technical complications during coronary angioplasty. It can put a patient’s life at risk.”
“There is difference in price as well. Few products are more expensive than ones in the market. Moreover, they do not have authorisation certificate from companies whose products they are selling,” he said.
Dr Yash Paul Sharma said, “There is no study or trial in the world which can prove that USFDA-approved stents are better than others.” On claims that stents provided by the AMRIT outlet are of inferior quality, he said, “They should prove it. We all know why some doctors are creating noise.” There was direct vendor system at the ACC. Representatives of large companies would enter into a rate contract with the PGI after quoting the lowest rates.
AMRIT has no supply from local vendors
“Private authorised distributors of three companies — Abbott, Medronics, Boston Scientific – are not willing to provide surgical products to the AMRIT outlet, but are directly dealing with the PGI, which is against the directives of the government,” said an official from AMRIT outlet.
First Published: Nov 18, 2016 19:57 IST